Market intelligence
BLSMSector not reported
BlossomHill Therapeutics, Inc. insider activity
In the last 90 days, 12 corporate insiders purchased $60,181,900 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 1
- 90-day purchase value
- $60,181,900
- Corporate buyers
- 12
- Latest transaction
- Aug 10, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
